13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Brain Structural Connectivity
The human brain is an incredibly complex and fascinating organ. A recent area of focus is its structural connectivity, or the way in which different parts of the brain are wired together. Structural connectivity can be studied using a variety of methods, including diffusion tensor imaging (DTI), magnetic resonance imaging (MRI), and positron emission tomography (PET). Structural connectivity is thought to play a role in various functions including memory, language, emotion, and decision-making. By examining the ways in which different brain regions are connected, researchers can better understand how these areas interact to produce complex behaviors. Additionally, understanding structural connectivity may provide insight into how the brain is wired and how it functions in certain disorders, such as autism spectrum disorders. DTI is the most widely used tool for mapping brain structural connectivity. It measures water diffusion as it moves in directions parallel to fibrous neural pathways. This data is used to compute an anisotropic diffusion tensor that helps to measure the overall connectivity of the pathways in a particular region of the brain. MRI and PET are also used to measure structural connectivity in the brain. MRI is used to generate detailed images of tissue and structures in the brain.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States